NEW DELHI: India will consider clinical trial data for the two full-dose Oxford-AstraZeneca Covid-19 vaccine candidates, which the firm says is 62% effective and not the “more complete half” dose regimen, which is claimed to be up to 90% effective, but has drawn criticism for dosing errors. the Indian governmentThe …
Read More »India to consider clinical trial data of two full doses of AstraZeneca vaccine | India News
